Hepatitis B Serological Markers
On this page
Direct answer
Hepatitis B serological markers are read as a set, because HBsAg, anti-HBs, HBeAg and anti-HBc together show whether a person is acutely infected, chronically infected, immune after vaccination or recovered from past infection. HBsAg persisting beyond six months defines chronic infection, and anti-HBs at 10 mIU/mL or more indicates protective immunity. During the window period, when HBsAg has disappeared but anti-HBs has not yet appeared, IgM anti-HBc is the marker that identifies acute infection.
What you must remember
- HBsAg: Surface antigen whose presence means infection; persistence beyond six months defines chronic hepatitis B.
- Anti-HBs: Neutralising antibody; a level of 10 mIU/mL or more is protective and is the only marker after successful vaccination.
- HBeAg: Marks active viral replication and high infectivity; its loss with appearance of anti-HBe generally indicates lower replication.
- IgM anti-HBc: Marks acute or recent infection and bridges the window period when HBsAg is already negative.
- Total anti-HBc: Indicates past or present infection, positive in both chronic carriers and recovered people, so it cannot separate them alone.
- HBV DNA: Quantifies viral load and guides treatment decisions in chronic infection.
- Isolated anti-HBc: Positive anti-HBc with negative HBsAg and anti-HBs suggests past infection, occult infection or a false positive, which needs HBV DNA testing.
Reading the panel pattern by pattern
Exam questions give a panel of results and ask for the diagnosis. Reading the panel is faster when each pattern is set against its meaning.
| Pattern | Interpretation |
|---|---|
| HBsAg+, IgM anti-HBc+ | Acute hepatitis B |
| HBsAg+, total anti-HBc+, IgM anti-HBc negative | Chronic hepatitis B |
| HBsAg−, anti-HBs+, anti-HBc+ | Recovered from past infection |
| HBsAg−, anti-HBs+, anti-HBc− | Vaccine-induced immunity |
| HBsAg−, IgM anti-HBc+, anti-HBs− | Window period of acute infection |
| HBsAg−, anti-HBs−, anti-HBc− | Susceptible |
The key decision is whether HBsAg persists beyond six months, because that separates acute from chronic disease. HBeAg and HBV DNA then guide whether a chronic carrier needs antiviral treatment. The markers reflect a moment in time, so results are read against the timing of exposure and the clinical story.
Where the exam tries to catch you
Serology items often hinge on one marker that changes the whole interpretation.
- Trap: Calling total anti-HBc positivity alone a chronic carrier. Correct: Total anti-HBc shows exposure, and chronic infection requires HBsAg persisting beyond six months.
- Trap: Reading negative HBsAg with positive IgM anti-HBc as no infection. Correct: That is the window period of acute hepatitis B, and IgM anti-HBc identifies it.
- Trap: Accepting anti-HBs of 5 mIU/mL as immunity. Correct: Protection requires 10 mIU/mL or more, so low responders may need a booster dose.
Frequently asked questions
What anti-HBs level indicates protection against hepatitis B?
Anti-HBs of 10 mIU/mL or more is considered protective against hepatitis B infection. Vaccinated people who fall below this level may need a booster dose and reassessment.
Which marker shows infectivity in hepatitis B?
HBeAg indicates active viral replication and higher infectivity, while HBV DNA quantifies the viral load. Loss of HBeAg with appearance of anti-HBe generally indicates lower replication.
How is the window period of hepatitis B identified?
During the window period HBsAg is no longer detectable while anti-HBs has not yet appeared, and IgM anti-HBc is positive. A positive IgM anti-HBc in that setting identifies acute hepatitis B.
What does isolated anti-HBc positivity mean?
Isolated anti-HBc, with negative HBsAg and anti-HBs, suggests past infection, occult hepatitis B or a false positive result. Hepatitis B DNA testing helps separate occult infection from resolved past disease.
When does hepatitis B become chronic?
Hepatitis B is considered chronic when HBsAg remains positive for more than six months after the initial infection. Chronic carriers are then assessed for HBeAg status, HBV DNA and liver disease.